Alpine Immune Sciences

-$0.37 (-3.51%) As of 4:11 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALPN and other ETFs, options, and stocks.

About ALPN

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases; immuno-oncology; and engineered cellular therapies.

CEO
Mitchell H. Gold
Employees
57
Headquarters
Seattle, Washington
Founded
2007

ALPN Key Statistics

Market Cap
245.52M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
43.55K
High Today
$10.65
Low Today
$10.25
Open Price
$10.65
Volume
15.32K
52 Week High
$16.37
52 Week Low
$7.21

ALPN Earnings

-$0.53
-$0.35
-$0.18
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure